Cabaletta Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
/ 
Frequently asked questions
To buy Cabaletta Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cabaletta Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cabaletta Bio Inc. is CABA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cabaletta Bio Inc. has its primary listing on NASDAQ. You can trade Cabaletta Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cabaletta Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Cabaletta Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Cabaletta Bio Inc..